Anew Medical licensed rights to certain technology and know-how in the field of gamma-melanocortins comprised of drug and peptide chemicals, API and pharmaceuticals that bind, affect, and potentially treat diseases directly or indirectly related to human MC1R receptors.
Melanocortin Receptor-Binding Ligands